In the BioHarmony Drug Report Database

"Preview" Icon

Arsenic trioxide

Trisenox (arsenic trioxide) is a small molecule pharmaceutical. Arsenic trioxide was first approved as Trisenox on 2000-09-25. It is used to treat promyelocytic leukemia acute in the USA. It has been approved in Europe to treat promyelocytic leukemia acute.

 

Trade Name

 

Trisenox
 

Common Name

 

arsenic trioxide
 

ChEMBL ID

 

CHEMBL2362016
 

Indication

 

promyelocytic leukemia acute
 

Drug Class

 

Antineoplastic agent

Image (chem structure or protein)

Arsenic trioxide structure rendering